IL33 and infection: Similar to the IL-33 treatment model, endogenous IL-33 protection was not restricted to binary toxin expressing strains as only 40% of ST2−/− mice survived attenuated R20291_cdtb infection, compared with 100% of wild-type mice (Supplementary Fig. 4g–i).